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Low-density lipoprotein receptors from adult human liver and the human hepatoblastoma cell line HepG2 
were analyzed by polyacrylamide lectrophoresis n SDS followed by immuno- and ligand botting. In both 
liver and HepG2 we detected a protein band with apparent relative molecular mass of 130 kDa, which is 
similar to that of the LDL receptor in fibroblasts. In addition we showed that HeLa cells also possess this 
LDL-receptor protein. 
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1. INTRODUCTION 
The liver is the most important organ in 
cholesterol homeostasis, since it can irreversibly 
remove large quantities of cholesterol from the cir- 
culation [1,2]. In animal models it has been shown 
that the majority of the LDL-uptake in the liver is 
receptor-mediated [3]. Furthermore, the presence 
of LDL receptors on human liver membranes [4] 
and on plasma membranes of the human 
hepatoblastoma-derived cell line HepG2 [5,6] has 
been demonstrated. LDL receptors from human 
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fibroblasts, A431 cells and rabbit and bovine 
adrenal tissue have been visualised by immuno- 
and ligand blotting techniques after polyacryl- 
amide electrophoresis [7,8]. Wade et al. [9] recent- 
ly used ligand blotting to detect LDL receptors in 
the liver from rabbit, rat and dog. It was further 
shown that these receptors have apparent relative 
molecular masses ranging from 128 (rabbit) to 
147 kDa (dog) (non-reducing electrophoresis con- 
ditions). The quantity and molecular mass of LDL 
receptors in adult human liver has, however, been 
a matter of controversy [lO,ll]. Hoeg et al. [12] 
reported the presence of two distinct LDL-binding 
proteins in human liver with apparent M, values of 
270000 and 330000. They did not detect a receptor 
protein of apparent molecular mass corresponding 
to that of LDL receptors of fibroblasts or adrenal 
glands. In the present work we show that adult 
human liver does indeed contain LDL receptors 
with characteristics very similar to those of the 
fibroblast receptor. We also demonstrate the 
presence of this receptor protein in HepG2 and 
HeLa cells. 
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2. MATERIALS AND METHODS with occasional stirring. The extract was clarified 
by ultracentrifugation at 6 x lo6 x gemin. 
2.1. Solubilization of cultured cells 
Fibroblasts, HeLa cells or HepG2 cells were 
grown on medium containing 10% lipoprotein 
deficient serum for two days before harvesting 
with a rubber scraper. The LDL receptor was ex- 
tracted by solubilizing the cells with 40 mM octyl- 
P-D-glucoside in buffer A (50 mM Tris/maleate, 
pH 6.5, 2 mM CaC12, 1.5 mM PMSF, 0.1 mM 
leupeptin) for lo-15 min on ice. The extract was 
c+arifi& by u+Lrac<nW&&0n z&t 6 X 1@ x g . min. 
2.3. Electrophoresis and blotting 
2.2. Preparation and solubilization of human liver 
membrane xtracts 
Human liver was obtained from hepatic tumor 
surgery, using only redundantly removed healthy 
tissue. For one experiment, a liver specimen was 
used from a patient homozygous for familial 
hypercholesterolemia, who did not express the 
fibroblast LDL receptor; this material, which came 
;avr&a!31e a&r Y&r trans@anla&n, ~a5 %n&~ 
provided by Dr H.B. Brewer (NIH, Bethesda). The 
tissue was put immediately into ice-cold isotonic 
SXl+r&, cti +X&J Wi?-& -%XXZ% Yi& ‘&&i ?iWz?_X +rl 
liquid nitrogen or used immediately. 
Samples of solubilized cells or liver membrane 
extracts were mixed with an equal volume of 2 x 
cont. sample buffer (without /?-mercaptoethanol) 
for SDS electrophoresis, either according to the 
system of Laemmli [13] or the system of Neville 
[14]. Bio-Rad high molecular mass standards were 
reduced by heating at 95°C for 5 min in sample 
b&&r ca&ini~g p-mercapW&WK?l. Af&er get 
electrophoresis, proteins were transferred elec- 
trophoretically to nitrocellulose (Schleicher & 
Schtill, 0.45 pm) for 16-18 h at 200 mA (blotting 
buffer: 20 mM Tris-base/l50 mM glycine, 20% 
methanol). The blot was saturated in 5% bovine 
serum albumin in 50 mM Tris-Cl, 90 mM NaCl, 
2 mM CaClz at pH 8 (4-6 h at 4°C). For im- 
munodetection, strips of the blot were incubated 
overnight at 4°C with polyclonal rabbit anti- 
bovine LDL-receptor antibodies or non-immune 
ra%r? X&Y+ +nWQ. Xncubalion %&Iers and 
washing procedures were essentially as described 
[7]. Bound antibodies were detected with 
. , 
All subsequent operations were carried out at 
0-4°C. The tissue was placed in buffer B (10 mM 
Tris-C1, pH 7.4, 150 mM IVaCI, 1 miVf CaClz and 
1 mM PMSF; 5 ml/g tissue) and homogenized 
with two 15-s pulses OF a Polytron homogenizer 
(setting 10). The homogenate was filtered through 
Nylon cloth (120,um mesh) and centrifuged at 
500 x g for 5 min. The supernatant was centri- 
fuged at 8000 x g for 15 min, the resulting 
postmitochondrial supernatant then being ultra- 
centrifuged for 60 min at 100000 x g. The pellet 
was resuspended in buffer B, using successively a
22-gauge and a 25-gauge needle, and centrifuged 
again at 100000 x g for 60 min. Finally, the mem- 
brane pellet was stored in liquid nitrogen or im- 
mediately solubilized. 
"~~GXiXdSt-CUiYj~kd WL XiYl;-i&tl~ 'I@ 
[Jackson> and 4-chloronaphthoL/H~O~. For ligand 
binding, blot strips were,incubated overnight with 
human LDL (40-80pg/ml), human IDL, 
~40--sO pg/‘ml) or apo E/pAospAo~ipid complexes 
(3 pug protein/ml). For controls, Ca’+ was replaced 
by 10 mM EDTA in the Iigand incubation bufFer. 
Bound ligand was detected either by incubation 
with rabbit antibodies against apo B or apo E, or 
hybridoma supernatant containing monoclonal an- 
tibodies against apo E (Beisiegel et al., in prepara- 
tion), followed by incubation with goat anti-rabbit 
(or anti-mouse) IgG-peroxidase conjugate and 
substrate as described above. Incubation buffers 
and washing procedures were according to the 
method described by Daniel et al. [a]. 
2.4. Preparation of lipoproteins 
For solubilization, membrane pellets were LDL and IDL were prepared from fresh frozen 
resuspended in buffer A (l-2 ml/g of starting wet plasma from normal or hyperlipidemic donors. 
liver tissue). The suspension was sonicated with an After centrifugation of the lipoprotein fraction 
MSE sonicator (two 5-s pulses, medium power, (d = 1.21 g/ml) in a modified Redgrave gradient 
ampl. 3). An equal volume of 80 mM octyl-P-D- [ 151 the LDL was taken from the density range d = 
glucoside in buffer A was added and the sample 1.050-l .060 g/ml and IDL from the density range 
was allowed to solubilize for lo-15 min on ice d = 1.019-1.035 g/ml. 
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2.5. Formation of apo Elphospholipid complexes 
(apo E/PC) 
VLDL was prepared from hyperlipidemic 
plasma by ultracentrifugation at density d = 
1.006 g/ml for 20 h at 100000 x g and respun 
under the same conditions. After delipidation with 
acetone/ethanol (1: 1, v/v) the apo-VLDL was 
subjected to preparative electrophoresis in the 
Neville system [14]. The apo E band was electro- 
eluted from the polyacrylamide using the elution 
columns of a Desaga electrophoresis chamber. The 
product was dialyzed extensively against 10 mM 
Tris-Cl buffer, pH 7.4, containing 140 mM NaCl 
and 1 mM EDTA (buffer C) to remove 
dodecylsulphate. A sample of the purified apo E 
was used for the formation of apo E/PC ac- 
cording to the method described by Helenius et al. 
[ 161 as modified by Schneider et al. [ 171. Briefly, 
a lipid film was formed in a glass tube by 
evaporating a solution of 2 mg phosphatidylcho- 
line (Serva) and 40 pg cholesterol (Serva) in chloro- 
form/ethanol under a nitrogen stream. 22Opg 
apo E, mixed with 23.4 mg of sodium cholate in 
buffer C, were added to the lipid film, which was 
then vigorously vortexed for 1 min and incubated 
at 24°C for 20 min prior to extensive dialysis 








Octylglucoside extracts of HeLa cells were sub- 
jected to electrophoresis according to Laemmli 
1131. The proteins were transferred onto 
nitrocellulose. A protein band of apparent M, 
130000 was detected which specifically bound anti- 
LDL-receptor antibodies. The same protein band 
interacted with LDL in a Ca’+-dependent manner 
(fig. 1). The relative electrophoretic mobilities of 
the LDL receptors from human skin fibroblasts or 
HeLa cells showed no significant difference. 
Fig.1. Immuno- and ligand blots of human skin 
fibroblasts and HeLa cells. Octylglucoside extracts of 
fibroblasts and HeLa cells were subjected to SDS- 
polyacrylamide electrophoresis and then electroblotted 
onto nitrocellulose. Lanes: 1, fibroblasts, anti-LDL- 
receptor immunoblot; 2, HeLa cells, anti-LDL-receptor 
immunoblot; 3, fibroblasts, non-immune rabbit IgG 
conotrol; 4, HeLa cells, non-immune rabbit IgG control; 
5, fibroblasts, LDL ligand blot; 6, HeLa cells, LDL 
ligand blot; 7, fibroblasts, LDL ligand blot + EDTA; 8, 
HeLa cells, LDL ligand blot + EDTA. Molecular mass 
markers (kDa): myosin (200); &galactosidase (116); 
phosphorylase b (92); bovine serum albumin (67); 
ovalbumin (45). 
We next used the immuno- and ligand blotting of extracted protein, applied to the gel (fig.2a). By 
techniques on blot strips of octylglucoside- applying the ligand blot procedure to these strips 
extracted human liver membranes. HeLa cell ex- (same electrophoresis and blotting run), using 
tracts were used for comparison. With polyclonal either LDL or IDL as ligand, we detected the same 
antibodies to bovine LDL receptor we detected a 130 kDa protein (fig.2b). LDL produced a 
single band of apparent A4, 130000 on blot strips somewhat weaker band than IDL, while the dif- 
from both HeLa extracts and human liver mem- ference in intensity of the LDL-receptor band be- 
brane preparations. The LDL-receptor band of tween HeLa and liver membrane strips was similar 
liver membranes was very strong in comparison to to that observed in the immunoblot procedure. In- 
that of HeLa cells, also relative to the total amount cubation in the presence of 10 mM EDTA 
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Fig.2. Immuno- and ligand blots of human liver membranes. Octylglucoside extracts of human liver membranes were 
subjected to electrophoresis and blotting. Blots represent approx. 85 pg extracted protein/blot strip (3 mm width). HeLa 
blot strips were used for comparison (25 pg extracted protein/strip). (a) Anti-LDL-receptor immunoblots. Lanes: 1 and. 
3, HeLa cells; 2 and 4, human liver membranes; 1 and 2, anti LDL-receptor; 3 and 4, non-immune rabbit IgG. (b) LDL 
and IDL ligand blots. Lanes: 1, 3, 5 and 7, HeLa cells; 2, 4, 6 and 8, human liver membranes; 1 and 2, LDL, anti-apo 
B; 3 and 4, IDL, anti-apo E; 5 and 6, LDL + EDTA, anti-apo B; 7 and 8, IDL + EDTA, anti-apo E. (c) Apo E/PC 
ligand blots. Lanes: 1 and 3, HeLa cells; 2 and 4, human liver membranes; 1 and 2, apo E 2/2 PC complexes, anti 
apo E; 3 and 4, apo E 3/3 PC complexes, anti apo E. Molecular mass markers are as in fig.1. 
prevented the binding of LDL and IDL to the 
130 kDa protein (fig.2b), showing that the interac- 
tion is Ca’+-dependent, as expected for the LDL 
receptor. In the ligand blotting experiment il- 
lustrated in fig.2c we used phospholipid complexes 
containing apo E as ligand. Complexes containing 
the apo E isoform 3/3 bound to LDL receptors on 
blots. However, no LDL receptor band was 
detected with complexes containing apo E2/2, a 
genetic variant which is not recognized by the 
LDL, receptor [17] (fig.2c). Controls were per- 
formed with phospholipid complexes (apo E3/3) 
in the presence of EDTA and with phospholipid 
complexes produced with bovine serum albumin 
instead of apo E (not shown). 
We used the polyclonal rabbit anti-LDL- 
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receptor antibody to test liver membranes from a 
patient who did not express the fibroblast LDL 
receptor (homozygous familial hypercholesterol- 
emia). In these liver membranes we could not 
detect any LDL receptor with the immunoblot pro- 
cedure. The same amount of normal liver mem- 
brane protein did show the 130 kDa LDL-receptor 
protein in control immunoblots (not shown). 
Experiments similar to those described above 
were carried out with extracts of HepG2 cells, us- 
ing the electrophoresis system of Neville [14]. 
Again, a protein band of apparent Mr 130000, hav- 
ing immunological and ligand binding properties 
characteristic of LDL receptors could be detected 
(fig.3). In these experiments the use of a 
monoclonal anti-apo E antibody as second step in 
Volume 216, number 2 FEBS LETTERS June 1987 
Fig.3. Immuno- and ligand blots of HepG2 cells. Lanes: 
1, 3, 5 and 6, HepG2 cells; 2 and 4, HeLa cells; 1 and 
2, anti-LDL-receptor; 3 and 4, non-immune rabbit IgG; 
5, IDL, monoclonal anti-apo E (hybridoma superna- 
tant); 6, control without monoclonal anti-apo E. 
Molecular mass markers are as in fig. 1. 
the ligand incubation procedure led to results 
essentially free from background staining (cf. figs 
2 and 3). 
4. DISCUSSION 
We have analyzed the LDL receptor in extracts 
of HeLa cells, human hepatoblastoma HepG2 cells 
and human liver membranes. HeLa cells were 
shown to possess LDL receptors with an apparent 
M, similar to that of normal human cultured 
fibroblasts, as detected on nitrocellulose blots 
(fig.1). Binding, uptake and degradation of LDL 
by HeLa cells display the characteristics of 
specific, receptor-mediated endocytosis (Beisiegel, 
U., unpublished). HeLa cells therefore provide a 
valid and convenient issue culture model for stu- 
dying ligand-receptor interactions of the LDL 
receptor. In the present investigation we used the 
LDL receptor of HeLa cells as reference material 
in blotting experiments. 
Binding and uptake of LDL in the human liver 
is mediated, at least in part, by LDL receptors 
[4,11,18]. In this paper we have shown that these 
receptors can be detected as a protein band of ap- 
parent M, 130000 on nitrocellulose blots after oc- 
tylglucoside extraction, electrophoresis under 
non-reducing conditions and blotting. No 130 kDa 
LDL receptor could be detected by immunoblot- 
ting using liver membranes from a patient lacking 
the fibroblast LDL receptor (homozygous familial 
hypercholesterolemia). 
Our findings, for the human liver, complement 
those of Wade et al. [9] on hepatic LDL-receptors 
of dog, rat and rabbit. Our results differ from 
those of Hoeg et al. [12], who detected 1251-LDL- 
binding proteins of M, 270000 and 330000 in 
human liver. As suggested by these authors, these 
bands may as well represent other proteins with 
LDL-binding activity. It remains unclear why they 
did not detect the 130 kDa LDL receptor. Varia- 
tions in hepatic LDL-receptor content between dif- 
ferent individuals may play a role in explaining this 
discrepancy. In our experiments, however, we ob- 
tained essentially identical results with liver mem- 
branes from two different subjects (male, 59 years 
old, hepatic tumor surgery, shown in fig.2; female, 
34 years old, healthy donor, not shown). In neither 
case did the quantity of LDL receptors found in 
our liver membrane xtracts provide an obstacle to 
detection. Moreover, in a personal communication 
Dr Brewer confirmed that in recent experiments 
the 130 kDa LDL receptor of human liver was in- 
deed detected in his laboratory. 
In accordance with the results obtained for 
human liver, we showed in this paper that human 
hepatoblastoma HepG2 cells also express an LDL- 
receptor protein of M, 130000. Our ligand blotting 
and immunoblotting experiments with the LDL 
receptor in HepG2 cells confirm earlier results of 
other laboratories, showing that HepG2 cells bind, 
internalize and degrade LDL via a receptor- 
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mediated pathway with kinetics similar to that of 
LDL receptors from extrahepatic ells [5,6,18]. 
Although hepatocytes certainly contribute to a 
large extent to the LDL binding capacity of the 
liver, *he relative conlribulion of hepatocytes, 
Kupffer cells and hepatic endothelial cells to the 
amount of LDL receptors contained in liver mem- 
brane extracts cannot be determined from the pre- 
sc%YL ~X~~s&X&. 
We conclude that LDL receptors in HeLa cells, 
HepG2 cells and human liver membranes, with 
rcSfi<< “r ~f??P~&~~ ~%SS ?&& 2&&Y&- ZYd 
ligand-binding specificities on nitrocellulose blots, 
are inciistinguishabl ‘from the fibrob’last LDL 
r c<c*r%w . T4m, G-htc+~ -fiwk+zfi se, -pi->~My WX iwa- 
ducts of the same human gene. 
During the preparation of this article an in- 
dependent study reported the detection and quan- 
titation of LDL receptors in human liver by ligand 
blotting, immunoblotting, and radioimmunoassay 
[LT. 
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